The European Scientific Advisory Board EU-RESPONSE is a research and preparedness network for pandemics and emerging infectious diseases (EU-RESPONSE). It is a 5-year multinational project coordinated by INSERM (France). It is funded by the European Union's Horizon 2020 Research and Innovation programme to design an adaptive European platform for clinical trials for COVID-19 and other emerging infectious diseases (SolidAct Trial) in order to assess the efficacy and safety of medicines. Hospitals from all over Europe may be involved in this framework. KCE is part of the independent Scientific and Ethical Advisory Board set up to advise on the structure of the platform EU-SolidAct, and on the medicines to be studied in priority.
CONTACT
ANNUAL REPORT
